Cas d’infection à la COVID-19 chez des personnes atteintes de sclérose en plaques (SEP) traitées par ocrelizumab (OCR) : actualisation des données de pharmacovigilance

por Hughes, Richard, Whitley, Louise, Schneble, Hans-Martin, Muros-Le-Rouzic, Erwan, Sauter, Annette, Pedotti, Rosetta, Köndgen, Harold
Publicado 2021

COVID-19 in ocrelizumab-treated people with multiple sclerosis

por Hughes, Richard, Whitley, Louise, Fitovski, Kocho, Schneble, Hans-Martin, Muros, Erwan, Sauter, Annette, Craveiro, Licinio, Dillon, Paul, Bonati, Ulrike, Jessop, Nikki, Pedotti, Rosetta, Koendgen, Harold
Publicado 2021

Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis

por Zuurbier, Susanna M, Hickman, Charlotte R, Tolias, Christos S, Rinkel, Leon A, Leyrer, Rebecca, Flemming, Kelly D, Bervini, David, Lanzino, Giuseppe, Wityk, Robert J, Schneble, Hans-Martin, Sure, Ulrich, Al-Shahi Salman, Rustam
Publicado 2019